Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
309 studies found for:    Ankylosing Spondylitis
Show Display Options
Rank Status Study
21 Completed
Has Results
Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab;   Other: placebo
22 Completed
Has Results
Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab (D2E7);   Biological: placebo
23 Completed Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach
Condition: Ankylosing Spondylitis
Intervention:
24 Recruiting Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: TNF alpha;   Drug: NSAIDs and sulfasalazine
25 Recruiting Physical Training Program in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Other: Personalized physical training program
26 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
27 Completed Study Evaluating Etanercept in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: etanercept
28 Completed An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: Enbrel (Etanercept)
29 Completed A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: MSC;   Drug: "celecoxib", "Celebrex®"
30 Completed
Has Results
Exercise Therapy Program in Ankylosing Spondylitis Patients
Condition: Ankylosing Spondylitis
Interventions: Other: mobility exercise;   Other: mobility and elastic resistance exercise
31 Completed A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.
Condition: Ankylosing Spondylitis
Intervention: Drug: infliximab
32 Recruiting A Multicenter Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Other: Placebo;   Drug: Bimekizumab
33 Completed Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: Etanercept
34 Completed Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy
Condition: Ankylosing Spondylitis
Intervention: Other: no intervention
35 Completed Clinical Trial of Osteoporosis in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
36 Completed A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Celecoxib 200 milligrams;   Drug: Celecoxib 400 milligrams;   Drug: diclofenac 50 milligrams
37 Recruiting The Effect of NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in the Spine in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: Golimumab;   Drug: Celecoxib
38 Completed Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: Enbrel (etanercept)
39 Completed
Has Results
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
Condition: Ankylosing Spondylitis
Intervention: Drug: Enbrel
40 Unknown  Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: infliximab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.